Warren Buffett's Market Warning Is Hard to Ignore. But I'd Buy These 3 Stocks Anyway.
Key PointsPharmaceutical giant Pfizer is in the midst of a transition that’s moving faster than most investors might think.
Warren Buffett has issued a market warning, citing the market's potential overvaluation. However, this should not deter investors, as there are still stocks worth owning. The author highlights three such stocks.
Pfizer (PFE) has faced challenges since the end of pandemic-induced demand for its products. However, the company is looking forward to the launch of eight new oncology drugs by 2030. A promising sign is its cancer-fighting drug Padcev, which had a 23% increase in sales in Q2 2023 compared to the previous year. Additionally, Pfizer's revenue base is less sensitive to economic fluctuations due to insurance reimbursements.
Alphabet (GOOG) (GOOGL) may seem vulnerable to the market's potential correction due to its heavy investment in AI and its reliance on advertising. Yet, Alphabet is well-positioned to capture growth in AI and has a dominant position in the internet market. Plus, in an uncertain economic environment, online advertising could see increased demand due to its cost-effectiveness.
Brookfield Renewable (BEPC) differs from traditional utility companies. Instead, it owns stakes in smaller utility companies in wind, hydroelectric, solar, and potentially nuclear power. Brookfield's business model is more resilient due to advancements in these energy sources. The company is targeting an average annual return, making it an attractive option despite the market concerns.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
